ACSS1


ACSS1: A Comprehensive Guide

Introduction:

ACSS1, also known as acyl-CoA synthetase short-chain family member 1, is a vital enzyme that plays a critical role in cellular metabolism. This blog post delves into the essential aspects of ACSS1, including its description, associated diseases, intriguing statistics, references, and the latest research findings.

Description:

ACSS1 is an enzyme that catalyzes the conversion of short-chain fatty acids into their coenzyme A derivatives. This process is crucial for energy production and cellular function. ACSS1 is primarily located in the mitochondrial matrix and is encoded by the ACSM5 gene.

Associated Diseases:

Defects in ACSS1 have been linked to several metabolic disorders:

  • Progressive familial intrahepatic cholestasis type 3 (PFIC3): A rare genetic liver disease characterized by severe cholestasis and liver failure.
  • Short-chain acyl-CoA dehydrogenase deficiency (SCAD): A mitochondrial disorder that affects the breakdown of short-chain fatty acids, leading to encephalopathic crises and cardiomyopathy.
  • Propionic acidemia: A metabolic disorder caused by an inability to break down propionic acid, resulting in developmental delays, cardiomyopathy, and neurological abnormalities.

Did you Know ?

  • ACSS1 deficiency is estimated to affect approximately 1 in 50,000 newborns worldwide.


Disclaimer: The information provided here is not exhaustive by any means. Always consult your doctor or other qualified healthcare provider with any questions you may have regarding a medical condition, procedure, or treatment, whether it is a prescription medication, over-the-counter drug, vitamin, supplement, or herbal alternative.